Evaxion Biotech AS (EVAX)

1.44 -0.24 (-14.29%) USD  |  NASDAQ  |  Nov 15, 16:00
1.40 -0.04 (-2.78%) After-Hours: 20:00
More

Evaxion Biotech Change in Payables and Accrued Expense (Quarterly)

Change in Payables and Accrued Expense (Quarterly) Chart

View Change in Payables and Accrued Expense (Quarterly) for EVAX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00

Historical Change in Payables and Accrued Expense (Quarterly) Data

View and export this data back to . Upgrade now.
Date Value

Change in Payables and Accrued Expense (Quarterly) Range, Past 5 Years

--
Minimum
--
Maximum
--
Average
--
Median

Change in Payables and Accrued Expense (Quarterly) Benchmarks

Ascendis Pharma AS --
DBV Technologies SA Upgrade
Adaptimmune Therapeutics PLC Upgrade
Akari Therapeutics PLC Upgrade
Biodexa Pharmaceuticals PLC --